| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.039 | 0.4 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.4 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.042 | 0.4 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.041 | 0.4 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |